China Medical System (OTCMKTS:CHSYF – Get Free Report) is anticipated to post its resultson Monday, March 16th. Analysts expect China Medical System to post earnings of $0.0415 per share and revenue of $604.7660 million for the quarter.
China Medical System Stock Performance
Shares of CHSYF opened at $1.35 on Monday. China Medical System has a 52 week low of $1.35 and a 52 week high of $1.64. The stock’s 50-day moving average price is $1.35 and its 200-day moving average price is $1.35.
About China Medical System
China Medical System (OTCMKTS: CHSYF) is a China-based pharmaceutical company engaged in the research, development, manufacturing and marketing of branded generic drugs. The company focuses on therapeutic areas including cardiovascular and metabolic diseases, oncology, autoimmune disorders and central nervous system conditions. Its product portfolio comprises both patented and off‐patent medicines, with key offerings such as anti-hypertensives, antidiabetic agents, oncology treatments and neuroprotective formulations.
Founded in 1993 and headquartered in Guangzhou, China Medical System conducts its operations primarily within mainland China, leveraging an extensive sales and distribution network that reaches hospitals, clinics and specialty pharmacies across more than 30 provinces.
Featured Stories
- Five stocks we like better than China Medical System
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with MarketBeat.com's FREE daily email newsletter.
